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Abstract: The increasing engineering of biomedical devices and the design of drug-delivery platforms
enriched by graphene-based components demand careful investigations of the impact of graphene-
related materials (GRMs) on the nervous system. In addition, the enhanced diffusion of GRM-based
products and technologies that might favor the dispersion in the environment of GRMs nanoparticles
urgently requires the potential neurotoxicity of these compounds to be addressed. One of the
challenges in providing definite evidence supporting the harmful or safe use of GRMs is addressing
the variety of this family of materials, with GRMs differing for size and chemistry. Such a diversity
impairs reaching a unique and predictive picture of the effects of GRMs on the nervous system.
Here, by exploiting the thermal reduction of graphene oxide nanoflakes (GO) to generate materials
with different oxygen/carbon ratios, we used a high-throughput analysis of early-stage zebrafish
locomotor behavior to investigate if modifications of a specific GRM chemical property influenced
how these nanomaterials affect vertebrate sensory-motor neurophysiology—exposing zebrafish
to GO downregulated their swimming performance. Conversely, reduced GO (rGO) treatments
boosted locomotor activity. We concluded that the tuning of single GRM chemical properties is
sufficient to produce differential effects on nervous system physiology, likely interfering with different
signaling pathways.
Keywords: graphene oxide; reduced graphene oxide; zebrafish larvae; sensory-motor nervous
system; synapses
1. Introduction
Thanks to their outstanding chemical and physical properties, graphene-related ma-
terials (GRMs) have been exploited in a wide range of applications, including energy
storage, electronics, the textile industry and medicine [1–3]. Although the potential of these
materials in terms of technological innovation is unquestionable, it is expected that the rise
in the use of GRMs containing products will increase the dispersion of graphene-based
nanoparticles in the environment as outcomes of the production processes and disposal [4].
Due to obvious concerns regarding GRMs impact on health, an increasing number of
studies addressed the effects of these nanomaterials on organism physiology [5–7] with a
focus on the nervous system [8–10].
In general, in contrast to pristine graphene, oxidized forms of graphene, named
graphene oxide (GO), specifically modulate vertebrate neurophysiological activity [11–13],
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an effect likely favored by the higher amount of oxygen functional groups that make GO
more reactive and dispersible in water-based solution [14]. In addition, thermally reduced
GO (rGO), presenting a decreased number of oxygen-containing groups and thus being
potentially less reactive, were found to interact with the subcellular components of nervous
tissue, such as the actin cytoskeleton, and to modulate neuronal function [15]. However,
due to the heterogeneity of GRMs, which can vary in size and chemical composition,
together with the different experimental conditions used to test GRMs [6], it has not been
elucidated whether the manipulation of a single property of GRMs, such as the degree of
GO reduction, could per se dictate the impact of the nanomaterial on neuronal function.
Early-stage zebrafish are an attractive model to study how GRMs affect the nervous
system. Together with a high level of DNA homology with the human genome [16], they
present an accessible and relatively simple nervous system, which shows many similari-
ties to that of mammals [17] and whose anatomy and physiology have been extensively
studied [18]. Furthermore, zebrafish larvae present a well-characterized repertoire of swim-
ming behaviors that are strictly dependent on the development of their sensory-motor
nervous system [19]. Furthermore, the analysis of their locomotor activity upon treatments
with molecules/materials can be used as an advantageous and reproducible approach to
screening their effects on nervous function [20]. This is contributing to the recent use of
zebrafish for studies of nanotoxicology and nanomedicine [21].
Herein, by combining thermal reduction of GO with high throughput kinematic
analysis of locomotor behavior in early-stage zebrafish, we proposed a simple method
to study the impact on the vertebrate sensory-motor system of a set of GRMs in which
only surface chemistry was varied. GO was thermally reduced at different temperatures
(650 ◦C, 1000 ◦C) to produce two forms of reduced GO, rGO650 and rGO1000. The
three materials were characterized by an increasing carbon/oxygen (C/O) ratio, while
morphology was kept unmodified. By testing zebrafish larvae locomotor behavior in a
light/dark alternation paradigm, we investigated whether short chronic incubation (lasting
between 2 and 24 h) with GO, rGO650 and rGO1000 modified their swimming performance
and spatial navigation strategy (measured as turn angle) in respect to the untreated controls.
In zebrafish larvae incubated with the three types of GRMs, we observed modifications of
the locomotor behavior positively correlated to the reduction degree of the material used. To
translate these results toward mammalian vertebrate neurophysiology, electrophysiological
recordings from in vitro rat neuronal cultures were performed and suggested that rGO
effects depend upon an interference of the nanomaterials with synaptic transmission.
2. Materials and Methods
2.1. Characterization of Nanomaterials
GO was obtained from Grupo Antolin company (Spain) within the framework of the
H2020 FET Flagship Graphene project. The GO was gently ground with a mortar and
pestle to homogenize the as-received powder. rGO was prepared using a two-step process
developed at CIRIMAT. First, the powder was slowly heated to 200 ◦C at 5 ◦C per minute
in a vacuum oven (10 mbar, overnight), leading to a first weight loss of ca. 59 wt.%. Then,
the powder was introduced in an alumina boat placed in a quartz tube and heated in a
tubular furnace up to a given temperature in argon atmosphere (10 ◦C per minute heating
rate) for 2 h after what the sample was cooled down to room temperature. Increasing
the temperature allows to increase the level of reduction of GO and to produce rGO with
different oxygen content. In this work, GO was reduced at 650 ◦C (rGO650) and 1000 ◦C
(rGO1000).
The specific surface area (SSA) was evaluated by N2 adsorption on dry powdered
samples using a Micrometrics Flow Sorb II 2300 (Micromeritics, Norcross, GA, USA)
conforming to the Brunauer, Emmett and Teller’s theory (BET). The SSA of the starting
GO was close to 220 m2/g. Following the reduction treatment, the SSA decreased to ca.
170 m2/g at 650 ◦C and was then stabilised at this value (measured at 175 m2/g after
reduction at 1000 ◦C).
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The ratio between carbon and oxygen was obtained by X-ray photoelectron spec-
troscopy (VG SCIENTA SES-2002 spectrometer (Scienta Omicron, Taunusstein, Germany)
provided by a concentric hemispherical analyser. As shown in Supplementary Figure S1A,
XPS analysis clearly evidenced the thermal reduction of GO with a significant decrease in
O/C atomic ratio from 41.6% in the starting GO to 12% (650 ◦C) and finally only 6.4% after
heating at 1000 ◦C. While the C1s band exhibited two peaks at 285 and 287.3 eV, correspond-
ing to sp2 carbon and carbon bonded to oxygen, respectively. The thinning of the first peak,
as well as its progressive downshift, are also indications of the progressive restoration of
the carbon sp2 network. Regarding the O1s band, the main peak at 533.1 eV in GO (C-OH,
C-O-C functions) progressively downshifted in energy, with a second main component at
531 eV becoming more and more predominant as the temperature increased. At 1000 ◦C,
the main remaining chemical functions may be attributed to C=O and C-OR [22].
TGA analysis was performed in argon atmosphere (at 1 ◦C/minute from room tem-
perature to 1000 ◦C (SETARAM TAG16) in a Pt crucible) in order not to burn the sample
but only to monitor its thermal decomposition (Supplementary Figure S1B). In the case
of the starting GO, the main weight loss was observed between 100 and 250 ◦C, with a
maximum speed at 163 ◦C. The total weight loss at 1000 ◦C was 55.8 wt.%. After reduction
to rGO, the thermal stability was greatly improved. In the case of the rGO650 sample, the
weight loss started to increase significantly only from 650 ◦C, while this was only from
850 ◦C for the sample reduced at the highest temperature. For rGO650, the final weight
loss was decreased to 19 wt.%, while it was only 6.3 wt.% after reduction at 1000 ◦C.
Recording of Raman spectra were performed at 632 nm (LabRAM 800, Jobin-Yvon)
and averaged on three spectra obtained at different places of the sample. As reported
in Supplementary Figure S1C, the intensity ratio between the intensity of the D band
(1328–1333 cm−1) and the G band (1589–1600 cm−1) was measured at 1.25 in the starting
GO. After reduction at 650 ◦C, it decreased to 1.16 before increasing to 1.65 after reduction
at 1000 ◦C—the higher this intensity ratio, the lower the structural quality of the sample.
Transmission electron microscopy (TEM, Supplementary Figure S1D) was performed
using a JEOL 1400 microscope operated at 120 kV. Samples were dispersed in ethanol, and
a few drops were deposited on copper grids (Lace Carbon). Particles have a crumpled
flake morphology, with a size typically ranging from 300 nm for the smallest ones to a few
micrometres for the largest ones. There was no obvious modification of the size or the
morphology with increasing levels of reduction.
Zeta potentials were measured for GO and rGO1000 at a concentration of 10 mg/L
in deionized water added with NaCl (final concentration of 1 mM, for a stabilized ionic
strength). Zeta potentials were −34.7 mV and −14.2 mV for GO and rGO1000, respectively.
The quantification of metals and other contaminants residues for the GRMs used in
this work is reported elsewhere and these concentrations were found to be too low to
produce significant toxicity in aquatic larvae [22].
2.2. Behavioral Assay on Zebrafish Larvae
Zebrafish (D. rerio) embryos were provided by the University of Trieste (Italy) animal
facility. Behavioral experiments were performed at the International School for Advanced
Studies (SISSA, Italy), where zebrafish were treated in accordance with the Italian law
(decree 26/14) and the EU guidelines (2007/526/CE and 2010/63/UE). The work was
approved by the SISSA Animal welfare and ethical review body.
Fertilized eggs were maintained in E3 solution, whose composition was (mM) 5 NaCl,
0.17 KCl, 0.33 CaCl2, 0.33 MgSO4, at the temperature of 28.5 ◦C and light:dark cycle of
(12:12 h) until the age of 4 or 5 days post fertilization (dpf), at which animals underwent
nanomaterials treatments. Before treatments, GO, rGO650 and rGO1000 were suspended in
E3 solution from a stock suspension at 1 mg/mL in distilled water to the final concentration
of 100 µg/mL. Animals were exposed to 0.5 mL of GRMs in a 24 multiwell plate in a range
of time between 2 and 24 h.
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The light–dark locomotion paradigm of zebrafish larvae, already reported for testing
various neuroactive compounds [20], was used to evaluate the effect of GO and rGO
nanosheets on the sensory-motor system at 5 dpf (Figure 1) in a high- throughput screening
system. The recording chamber for the locomotor behavior was equipped by Infra-Red (IR)
backlight unit interfaced with monochrome IR sensitive camera GigE (Blaser, 60 frames
per second). The chamber was provided by light–dark module to allow the stimulation
and temperature control of 27 ◦C. After 20 min adaptation to the recording chamber, the
locomotor test consisted of four consecutive cycles of 10 min alternating light and dark.
For each experimental condition, we tested at least N = 48 larvae. Analysis of total distance
moved, mean speed and mean of absolute turn angle were performed by EthoVision XT
(Noldus, The Netherlands) software. In graphs, data were plotted as 2 min of time bins,
while statistical analysis was done on the entire 10 min periods of light or dark. To avoid
repetitions, p values, when reported in the text, refer only to the first periods of light and
dark, although results were confirmed in the following light–dark alternations, as depicted
in the figures.
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Figure 1. Experimental design of GRMs high throughput screening by using zebrafish larvae. (A) 
rGO was obtained by thermal reduction of GO at 650 and 1000 °C. Early-stage zebrafish (5 dpf) were 
treated chronically with GRMs and (B) used as behavioral model to investigate the effect of GRMs 
on the sensory-motor nervous system. (C) After behavioral experiments, animals were analyzed for 
anatomical traits and spinal cord characterization. 
Figure 1. Experimental design of GRMs high throughput screening by using zebrafish larvae. (A) rGO was obtained
by thermal reduction of GO at 650 and 1000 ◦C. Early-stage zebrafish (5 dpf) were treated chronically with GRMs and
(B) used as behavioral model to investigate the effect of GRMs on the sensory-motor nervous system. (C) After behavioral
experiments, animals were analyzed for anatomical traits and spinal cord characterization.
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2.3. Morphological and Survival Analysis of Zebrafish Larvae
For the morphometric analysis after 24 h of treatment, larvae were anesthetized with
0.02% of MS222 (Sigma), fixed with 4% paraformaldehyde (PFA) for 90 min at room
temperature (RT) and washed in PBS. Fixed larvae were mounted on a glass coverslip and
acquired using EVOS XL Core Imaging System with 4× objective. In order to evaluate the
developmental stage, the following anatomical traits were considered: larvae length as the
distance from caudal peduncle to snout, larvae height as distance from ventral (anterior
edge of the anal fin) to dorsal margin, yolk diameter as the distance at the shorter axis [13].
For each nanomaterial, we analyzed N = 36 larvae. Measures of anatomical traits were
performed using Fiji software. Mortality was assessed as lack of heart beating after 24 h
of treatment.
2.4. Whole Mount Immunofluorescence on Zebrafish Larvae
Immunofluorescence staining was performed, modifying the protocol of Turner [23].
Zebrafish larvae were sweet-fixed using 4% PFA with 4% sucrose in PBS for 5 h at RT and
washed using PBTr (PBS with 0.8% Triton). Larvae were dehydrated using solutions at
increasing concentrations of MeOH in PBTr (50–75–100%) before storing at −20 ◦C for at
least 6 h. After rehydration, they were permeabilized and digested with Proteinase K in
PBTr (1 µg/mL). Next, larvae were post-fixed for 20 min in 4% PFA, then washed with
PBTr and the blocking of endogenous binding sites was performed using a solution of NGS
(10%), DMSO (1%) in PBTr for 1 h. Anti-acetylated tubulin mouse monoclonal (Sigma)
was diluted in blocking solution (1:500) and incubated at 4 ◦C for 72 h. Subsequently, the
larvae were washed in PBTr and incubated at 4 ◦C with secondary antibody Alexa 488 goat
anti-mouse (1:500, Invitrogen) in blocking solution overnight. After washing out, samples
were transferred in solutions with increasing concentrations of glycerol in PBS (25–50–80%)
and mounted on glass coverslips.
Acquisition of images were performed using Nikon A1R confocal microscope, equipped
with 488 nm and 640 nm solid-state laser, with 10× (0.45 NA), 20× (0.75 NA) and 40×
(0.95 NA) objectives and confocal sections were taken every 0.775 µm up to collect im-
ages through the entire larva thickness. For each experimental condition we analyzed at
least N = 7 larvae. Fiji software was used to carry out the analysis of fluorescence intensity
and spinal cord diameter. In the spinal cord, we measured the intensity of fluorescence
between segments 8 and 13 and derived the diameter of the spinal cord at segment 10.
2.5. Analysis of GRMs Dispersion Behavior in E3 Solution
The dispersion ability of the three nanomaterials was calculated in the E3 solution
using a TurbiscanTM LAB Stability Analyzer (Formulaction SA, Toulouse, France). Trans-
mission and backscattering of infrared light source (880 nm) were measured every 40 µm
of the sample height. In order to guarantee the detection of the nanoparticles, the concen-
tration of 100 µg/mL of GO and rGO materials was selected for dispersion monitoring
during 24 h, and the dispersion protocol was exactly the one described above.
2.6. Preparation of Rat Neuronal Cultures
Primary hippocampal cultures were obtained from 2 to 3 days postnatal (P2−P3)
rats [12]. All procedures were performed with the approval of veterinary authorities and
in accordance with the Italian law (decree 26/14) and the EU guidelines (2007/526/CE and
2010/63/UE). The animal use was authorized by the Italian Ministry of Health (authoriza-
tion number: 22DAB.NYQA). All efforts were made to reduce the number of animals used
and minimize suffering. All chemicals were purchased from Sigma unless stated otherwise.
Enzymatically dissociated hippocampal neurons were seeded on poly-L-ornithine-coated
glass coverslips (24 × 12 mm2, Kindler, EU) at a density of 250,000 ± 18,000 cells/mL (mea-
sured by sampling N = 4 culture series). Neuronal cultures were incubated (37 ◦C, 5% CO2)
in medium consisting of 1×MEM (Gibco), 35 mM glucose, 1 mM Apo-transferrin, 15 mM
HEPES, 1 mM insulin, 4 µM biotin, 3 µM vitamin B12, 500 nM gentamicin, and 10% fetal
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bovine serum (FBS; Invitrogen). After two days, the culture medium was renewed with the
addition of 1B-arabinofuranosilcitosina (Ara-C, 5 µM), to prevent glial over-proliferation,
and hereafter changed every two days.
Regarding the chronic treatments, cultures were incubated at two days in vitro (DIV),
with a medium containing 10 µg/mL of rGO1000. The controls were subjected to the same
medium changes replaced by equivalent volumes Milli-Q water. Cultures were used at
days 8–10 (after 6–8 days of treatment).
2.7. Electrophysiological Recordings
Single whole-cell recordings were collected using dissociated hippocampal cultures
at RT with pipettes (5−7 MΩ) containing (in mM) 120 K gluconate, 20 KCl, 10 HEPES,
10 EGTA, 2 MgCl2, 2 Na2ATP, pH 7.3; osmolarity was adjusted to 300 mOsm. The extracel-
lular solution contained (in mM) 150 NaCl, 4 KCl, 1 MgCl2, 2 CaCl2, 1 MgCl2, 10 HEPES,
10 glucose, pH 7.4. Cultures were placed in a Perspex chamber mounted on an inverted
microscope (Eclipse TE-200, Nikon, Japan). Recordings were acquired by Multiclamp
700B patch amplifier (Axon CNS, Molecular Devices) and digitized at 10 kHz with the
pClamp 10.2 software (Molecular Devices LLC, San Jose, CA, USA). Spontaneous synaptic
activity was collected by clamping the membrane voltage at −56 mV holding potential
(not corrected for liquid junction potential, which was −14 mV). The recorded traces were
analyzed offline with the AxoGraph 1.4.4 (Axon Instrument) event detection software
(Axon CNS, Molecular Devices). Data were recorded from N = 17 control and N = 19
rGO1000-treated cultures.
2.8. Immunofluorescence Labelling of Rat Cultures
Hippocampal neurons and glial cells were fixed in PBS containing 4% PFA for 20 min
at RT. Cells were permeabilized with 1% Triton X-100 for 30 min, then blocked with
5% FBS in PBS for 30 min at RT and incubated with primary antibodies for 30 min. In
order to label the neurons astrocytes and glutamate vesicles, we used rabbit polyclonal
anti-β-tubulin III (Sigma T2200, 1:250 dilution), mouse monoclonal anti-GFAP (Sigma-
Aldrich, Missouri, USA, 1:500 dilution) and guinea pig polyclonal anti-vesicular glutamate
transporter (Millipore AB5905, 1:2000 dilution), respectively. After the primary antibodies
and PBS washes, cells were incubated for 30 min with the secondary antibodies Alexa
Fluor 594 goat anti-rabbit (Invitrogen, 1:500 dilution), Alexa Fluor 488 goat anti-mouse
(Invitrogen, 1:500 dilution), Alexa Fluor 488 goat anti-guinea pig (Invitrogen, 1:500) and
DAPI (Invitrogen, 1:200 dilution) to reveal the nuclei. Samples were mounted in Vectashield
(Vector Laboratories) on 1 mm thick coverslips. Cell densities were quantified at 20×
(0.5 NA) magnification using a Nikon C2 Confocal Microscope (Nikon, Japan), with random
sampling of random fields for control and treated cultures. Data were analyzed in three
different culture series for a total number of 35 fields for each treatment.
The images acquisition of VGLUT1-positive terminals were performed using the same
confocal microscope, with 60× (1.4 NA) magnification (Z-stacks were taken every 300 nm;
16 visual fields for each conditions). The analysis was performed offline using the Volocity
software (Volocity 3D image analysis software, PerkinElmer, Waltham, MA USA). During
each experimental session, the images were acquired using the same exposure settings. The
regions of interest (ROI) for the quantification were chosen using the tubulin channel and
Z-stacks were used to quantify VGLUT1 puncta as 3D objects. Each value was normalized
to the corresponding cellular volume calculated in relation to the β-tubulin III labeling.
Data were analyzed in three different culture series for a total number of 16 fields for
each treatment.
2.9. Statistical Analysis
Data from the same experimental condition were pooled together and presented as
mean ± SEM. The statistical distribution of the data was evaluated using the D’Agostino–
Pearson omnibus normality test.
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For the statistical analysis of zebrafish experiments, in the case of distance moved,
speed, and turn angle, we performed two-way ANOVA. In contrast, we used one-way
ANOVA followed by Dunnett’s multiple comparison tests for the survival, morphometric
and fluorescent analysis.
For electrophysiological experiments, the Student’s t-test was used to assess the
statistically significant difference between two data sets.
The threshold of significance was determined using the NEJM p-value style: p < 0.033
(*), p < 0.002 (**), p < 0.001 (***).
3. Results
In this work, we used early-stage zebrafish as a screening tool [20] to investigate
whether the degree of thermal reduction of GO could affect the functionality of the sensory-
motor system and the correlated locomotor behavior. To this aim, we incubated at a
concentration of 100 µg/mL in brief chronic treatments (ranging between 2 and 24 h)
zebrafish larvae with three types of graphene oxide (GO, rGO650 and rGO1000). These
differed for the degree of reduction (and therefore for the C/O ratio) while the morphology
was unmodified (as shown in the characterization reported in Supplementary Figure S1).
However, the reduction of GO is known to increase both its electrical conductivity and
hydrophobicity by progressive restoration of the graphitic network when increasing the
degree of the reduction [24]. At the end of the exposure, we first analyzed zebrafish loco-
motor behavior through a high throughput screening approach and then we characterized
some anatomical aspects of the treated larvae (Figure 1).
At 5 dpf, zebrafish larvae swim spontaneously and can modify their locomotor activity
in response to sensory stimuli [25]. Such activity is controlled by spinal cord neuronal
networks, that after integrating incoming sensory information, control skeletal muscles via
neuromuscular junction [26].
A well-characterized paradigm to study the activity of sensory-motor system and
correlated emerging behaviors upon exposure to drug/particles/compounds is the light–
dark locomotion test in which zebrafish locomotor activity is analyzed during alternated
periods of light and dark [27–29]. At this developmental stage, the dark–light transition
directly triggers a fear response detectable as a decrease in locomotor activity [27,30]. The
light–dark transition drastically increases the locomotor activity as an evidence that at this
age larvae show natural preference for the dark environment [31,32].
We observed this pattern of locomotor activity in our zebrafish larvae, however already
after two hours of GRMs exposure we detected some modifications in the swimming
activity of nanomaterials treated larvae (Figure 2A). In detail, during each light–dark
transition, we observed that the exposure to GO produced a decrease in the distance
moved when compared to control (for GO treated: 924± 93 mm, for control: 1434 ± 93 mm;
p < 0.001, Figure 2A), with an effect that was prominent in the last part of the dark period.
Such reduced locomotor performance was confirmed at 4 and 6 h of exposure time (at
4 h: for GO treated: 889 ± 107 mm, for control: 1484 ± 111 mm; at 6 h: for GO treated:
624 mm ± 68 mm, for control: 1728 ± 93 mm; Figure 2B,C, p < 0.001 for each treatment).
Differently, when larvae were incubated for 2, 4 or 6 h with rGO650, they presented a
locomotor activity that was comparable to that of the untreated controls (for rGO650: at
2 h, 1441 ± 74 mm, at 4 h, 1316 ± 117 mm and at 6 h, 1739 ± 103 mm, Figure 2A–C). When
increasing the reduction degree of GO, in rGO1000, after 2 h we detected no differences
(1540 ± 92 mm), with an improvement in the distance moved detected after 4 h of treatment
(at 4 h, 2087 ± 141 mm and at 6 h, 2036± 112 mm; Figure 2A–C, p values between 0.033 and
0.001). Interestingly, when comparing the effects on locomotion between GO and rGO1000,
all exposure times showed significant (p < 0.001) differences in the distance moved.
These experiments showed that brief chronic incubations with GO with different
degrees of thermal reduction affect the locomotor activity of zebrafish larvae in the opposite
manner. While the exposure to GO induced a decreased locomotor performance that
Nanomaterials 2021, 11, 2161 8 of 17
emerged quickly after two hours from the incubation, the rGO1000 presented a delayed
impact that resulted in an opposite outcome, the increment of locomotor activity.
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i r . I act of GRMs with different degr es of thermal reduction on l com tor behavior upon
a 6 h-long treatments. Locomotor activity was analyzed by measuring the distance moved and
the turn angle (left and right columns, respectively). Animals were subjected to light (white bars) and
dark (grey bars) alternating periods of 10 min each one. The controls (CTRL) are showed in black,
GO in green, rGO650 in orange and rGO1000 in red. (A–D) Line plots after 2, (B–E) 4 and (C–F)
6 h of treatment. Results are expressed as Mean ± SEM of 2 min per bins. Statistical significance of
treatment respect to the CTRL are expressed as * p < 0.033, ** p < 0.002, *** p < 0.001 and refers to 10
min of behavioral recordings, the entire light or dark period of stimulation.
Next, we investigated which aspects of the locomotor behavior could be modified by
the treatments with the GRMs with different reduction degree. We considered two factors,
the speed of swimming and the navigation strategy.
Regarding the first, we observed that when animals were incubated for 2, 4 or 6 h with
GO presented a decrease in speed respect to untreated control. The averaged values of speed
for GO treated larvae were: 1.8 ± 0.2 mm/s at 2 h, 2 ± 0.3 mm/s at 4 h and 1.7 ± 0.2 mm/s
at 6 h. For controls, instead, they were: 3.2 ± 0.2 mm/s at 2 h, 3.4 ± 0.2 mm/s at 4 h,
4 ± 0.2 m/s at 6 h; all p values < 0.001, Supplementary Figure S2A–C). Although ani-
mals treated with rGO1000 presented a tendency to increase their swimming speed after
4 h of treatments, animals incubated with reduced materials did not show statistically
significant differences for this parameter respect to the controls. Averaged speeds were
3.1 ± 0.1 mm/s at 2 h, 3 ± 0.3 m /s at 4 h and 4 ± 0.2 mm/s at 6 h for the rGO650, while
they were 3 ± 0.2 mm/s at 2 h, 4 ± 0.3 mm/s at 4 h and 4.3 ± 0.2 mm/s at 6 h for the
rGO1000 (Supplementary Figure S2A–C). These results showed that GO treated larvae
moved a shorter distance as they swam to a reduced speed, while for those treated with
Nanomaterials 2021, 11, 2161 9 of 17
rGO1000, the increment in the distance moved could be only in part influenced by a trend
of increment in swimming speed.
The navigation strategy was measured as turn angle used by the animal to change
the moving direction of the body’s central point [33–35]. In untreated controls, the turn
angle varied within the light–dark cycle: during the light period, turn angle increased (for
instance, the turn angle at 4 h was 76 ± 3◦), while in the dark period it decreased (64 ± 7◦,
Figure 2). Our findings reported that GO completely destroyed the pattern of turn angle
observed in control animals measured from 2 to 6 h exposure time (for GO treated animals,
at 4 h, the turn angle was 100 ± 4◦ during light and 99 ± 19◦ during dark, Figure 2D–F,
p < 0.001 for each temporal point respect to the controls). Such effect was specific for GO,
as animals treated with rGO650 and rGO1000 presented the same pattern of turn angle as
in control counterparts (for rGO650 treated animals, turn angle was 88 ± 5◦ during light,
68 ± 14◦ during dark; for rGO1000 treated animals, 80 ± 3◦ during light, 71 ± 8◦ during
dark; Figure 2D–F). These results revealed that GO modified the navigation strategy of
zebrafish larvae, but when thermally reduced, GRMs lost this ability.
In the next set of experiments, we incubated zebrafish larvae with GRMs for 24 h to see
if the observed effects were long-lasting and/or could be potentiated by a longer incubation.
Respect to the controls, we observed that 24 h treatments with rGO1000 induced an in-
crement of the locomotor performance, measured as enhanced distance moved (Figure 3A).
This was detectable both during light (for the control, 895 ± 58 mm; for the rGO1000
treated, 1026 ± 84 mm) and dark periods (for the control, 1337 ± 62 mm; for the rGO1000
treated, 1999 ± 95; p-values between 0.001 and 0.002 when compared to the untreated
control). Similarly, animals treated with rGO650, showed an increased distance moved
(1667 ± 86 mm), but only in the dark period (Figure 3A, p < 0.002). These effects could be
dependent on the statistically significant increment in the swimming speed (for control:
3 ± 0.1 mm/s, for rGO650 treated: 3.8 ± 0.2 mm/s, for rGO1000 treated: 4.3 ± 0.2 mm/s;
p values between 0.033 and 0.001, Supplementary Figure S2D).
Regarding the analysis of turn angle, both rGO650 and rGO1000 presented the same
pattern of navigation strategy as in control counterpart (for control, total turn angle was
68 ± 2◦ during light and 59 ± 1◦ during dark; for rGO650 treated, 70 ± 2◦ during light and
60 ± 1◦ during dark; for rGO1000 treated, 68 ± 3◦ during light and 59 ± 1◦ during dark;
Figure 3B).
Conversely, in comparison with the controls, GO-treated animals after 24 h did
present alterations neither in the distance moved nor in the speed (for the distance moved:
1505 ± 114 mm; for speed: 3 ± 0.2 mm/s). However, the turn angle was still completely
altered (82 ± 3◦ during light and 77 ± 2◦ during dark, p < 0.001; Figure 3B).
Anatomical traits of zebrafish larvae treated with GRMs for 24 h were analyzed
in order to understand if the modifications of the locomotor performance could arise
from developmental morphological alterations. No changes in larvae length (for control:
3.22 ± 0.04 mm, for GO: 3.13 ± 0.05 mm; for rGO650: 3.24 ± 0.06 mm, for rGO1000:
3.21 ± 0.05 mm), height (for control: 0.21 ± 0.007 mm, for GO: 0.19 ± 0.008 mm; for
rGO650: 0.21 ± 0.007 mm, for rGO1000: 0.21 ± 0.008 mm) and yolk diameter (for control:
0.39 ± 0.01 mm, for GO: 0.35 ± 0.01 mm; for rGO650: 0.36 ± 0.01 mm, for rGO1000:
0.35 ± 0.01 mm, Figure 3D–F) were found. In addition, the rate of larvae survival was
similar among the different treatments (for control: 100 ± 0.00%, for GO: 92 ± 5%; for
rGO650: 97 ± 3%, for rGO1000: 97 ± 3%, Figure 3C).
A rough histological analysis of the nervous system was performed through immunos-
taining against the neuronal marker acetylated-tubulin [23]. In immunostained larvae, we
analyzed the fluorescence intensity and the diameter of the spinal cord, but we could not
find statistically significant differences in these parameters. The intensity of fluorescence
was for control: 66 ± 12 a.u., for GO: 65 ± 20 a.u., for rGO650: 70 ± 9 a.u. and for rGO1000:
70 ± 19 a.u. (Figure 3G–H), while the calculated spinal cord diameter was for the control:
47 ± 3 µm, for GO: 48 ± 1 µm, for rGO650: 46 ± 1 µm and for rGO1000: 46 ± 2 µm,
(Figure 3G–I).




Figure 3. Representations of 24-h-long chronic exposure of zebrafish larvae to GRMs. Locomotor 
activity of larvae subjected to light and dark alternating 10 min periods was analyzed for the dis-
tance moved (A) and turn angle (B). Bar plots reported the anatomical analysis of larvae (in the inset 
on the top, the measured parameters), respectively the survival (C), larvae length (D), height (E) 
and yolk diameter (F). On the bottom, a representative image of a whole mounted larvae labelled 
with the neuronal marker acetylated-tubulin (Ac-Tub), while on the top the spinal cord region in 
the red square is magnified (G). Bar plots of the Ac-tub fluorescence intensity (H) and spinal cord 
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cells were directly exposed to the nanomaterials. Thus, we adjusted the dose of GRM to a 
previously found value to modulate neuronal activity without causing cell death in dis-
sociated neuronal cultures [12]. As the effects of GO on synaptic activity have been re-
ported elsewhere [12,13], we preferred to focus on rGO1000 considering its strong impact 
on zebrafish behavior after 24 h of incubation. 
Neuronal passive membrane properties, indicators of the degree of maturation and 
health of neurons [36,37] were measured in control neurons and rGO 1000 treated ones, 
and there were no difference in cell capacitance (82 ± 12 pF in control and 81 ± 14 pF in 
Figure 3. Representations of 24-h-long chronic exposure of zebrafish larvae to GRMs. Locomotor
activity of larvae subjected to light and dark alternating 10 min periods was analyzed for the distance
moved (A) and turn angle (B). Bar plots reported the anatomical analysis of larvae (in the inset on
the top, the measured parameters), respectively the survival (C), larvae length (D), height (E) and
yolk diameter (F). On the bottom, a representative image of a whole mounted larvae labelled with
the neuronal marker acetylated-tubulin (Ac-Tub), while on the top the spinal cord region in the red
squar is magnified (G). Bar plots of the Ac-tub fluoresce ce inten ity (H) and spinal cord diameter
(I). Statistical significance reported to the CTRL and expressed as ** p < 0.002, *** p < 0.001.
These results indicated that brief chronic exposure to GO with different degrees of
reduction did not induce larvae morphological and cytological alteration of the spinal cord.
We hypothesized that the observed modifications of locomotor behavior could result from
an interference of nanomaterials with the function of the sensory-motor nervous system,
such as the synaptic communication between neurons.
In order to investigate the potential effect of these nanomaterials at synaptic level and
to validate these results for translation in the nervous system of not aquatic vertebrates,
we used dissociated rat neuronal cultures to measure synaptic activity upon 6–8-day-
long lasting treatments with 10 µg/mL of rGO1000 (Figure 4A). Different from zebrafish
treatments in which 100 µg/mL of nanomaterials was administered in the water and
presumably only a lower amount reached the nervous system, in these experiments,
neuronal cells were directly exposed to the nanomaterials. Thus, we adjusted the dose of
GRM to a previously found value to modulate neuronal activity without causing cell death
in dissociated neuronal cultures [12]. As the effects of GO on synaptic activity have been
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reported elsewhere [12,13], we preferred to focus on rGO1000 considering its strong impact
on zebrafish behavior after 24 h of incubation.
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were analyzed through the patch-clamp technique to monitor neuronal activity. (B) Exemplificative 
voltage-clamp traces recorded at −56 mV of holding potential from cultures of control and those 
treated with rGO1000 (10 µg/mL for 6–8 days in vitro). Bar plots show pooled data and summarize 
average sPSCs frequency (C) and amplitude (D). Note the significant increase in rGO1000 treated 
cultures for both sPSC frequency and amplitude. (E) Immunofluorescence images are represented 
to observe neurons and glial cells in the two different conditions (anti-β-tubulin III in red; anti-GFAP 
in green; in all, nuclei are shown with DAPI in blue). The plots summarize neuronal (F) and glial 
(G) densities in the different conditions. (H) Confocal reconstructions of control and rGO1000 
treated neurons stained for the vesicular glutamate transporter 1 (VGLUT1 in green) and co-immu-
nolabelled for cytoskeletal component β-tubulin III (red; nuclei are stained with DAPI in blue). (I) 
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Figure 4. Chronic incubation of dissociated neuronal cultures with rGO1000 boosts synaptic activity.
(A) Dissociated neuron l cultures were obtained from a rat brain and after exposure to rGO1000,
were analyzed through the patch-clamp technique to monitor neuronal activity. (B) Exemplificative
voltage-clamp traces recorded at −56 mV of holding potential from cultures of control and those
treated with rGO1000 (10 µg/mL for 6–8 days in vitro). Bar plots show pooled data and summarize
average sPSCs frequency (C) and amplitude (D). Note the significant increase in rGO1000 treated
cultures for both sPSC frequency and amplitude. (E) Immunofluorescence images are represented to
observe neurons and glial cells in the two different conditions (anti-β-tubulin III in red; anti-GFAP in
green; in all, nuclei are shown with DAPI in blue). The plots summarize neuronal (F) and glial (G)
densitie in the different co ditions. (H) Confocal reconstructions of control a d rGO1000 treated
n urons stained for the vesicular glutamate tr nspor er 1 (VGLUT1 in green) and co-immun labelled
f r cytoskeletal c mponent β-tubulin III (red; nuclei are stained with DAPI in blue). (I) Bar plot
shows the statistically significant increase of VGLUT1-positive puncta in rGO1000 treated cultures
respect to the control. Statistical significance expressed as * p < 0.033, *** p < 0.001.
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Neuronal passive membrane properties, indicators of the degree of maturation and
health of neurons [36,37] were measured in control neurons and rGO 1000 treated ones,
and there were no difference in cell capacitance (82 ± 12 pF in control and 81 ± 14 pF in
rGO1000 treated cells) and input resistance (441 ± 22 MΩ in control and 600 ± 31 pF in
rGO1000 treated cells). This indicated that neurons were healthy after exposure to the
rGO1000 treatments and their development was not impaired by the nanomaterial.
Next, spontaneous postsynaptic currents (sPSCs) were acquired using single-cell
patch-clamp electrophysiology to detect the activity of the neuronal networks. As shown
in Figure 4B, where some representative current tracings of synaptic activity recorded in
the two conditions are reported, rGO1000 treated neurons presented a significant increase
in sPSCs frequency (from 3.5 ± 0.4 Hz in control to 5 ± 0.3 Hz in rGO1000-treated cultures,
p < 0.033, Figure 4C) and in amplitude (from 54 ± 3 pA in controls to 89 ± 9 in rGO1000
treated cells, p < 0.001, Figure 4D).
Neural network efficacy can be affected by the number of neurons and synapses
embedded in the network. Thus, to evaluate changes in these structural entities first
we estimated the dimension of the network in the two culture groups. To this aim, to
visualize neurons and astrocytes, we used immunofluorescence for the specific cytoskele-
tal components β-tubulin III and glial fibrillary acidic protein (GFAP), respectively [12].
Then, we quantified the density of the two cell types in cultures that have undergone the
two treatments.
We identified both β-tubulin III and GFAP immunoreactive cells in the two conditions
(Figure 4E) and both cell groups were expressed in a comparable ratio in all treatment
groups. Control cultures presented a neuronal density of 260 ± 20 cells/mm2 comparable
to that measured in rGO1000 treated ones (246 ± 17 cells/mm2, Figure 4F). Similarly,
rGO1000 did not affect astrocyte density, as control cultures presented a glial density
of 99 ± 6 cells/mm2, which was not significantly different respect to that measured in
rGO1000 ones (106 ± 5 cells mm2, Figure 4G). Thus, we could exclude that the increment
in neuronal activity observed in electrophysiological experiments was due to differences in
network size in the two conditions [12].
To determine whether changes in synaptic activity could be related to structural modi-
fications of synapses, neurons were immunostained for both β-tubulin III and the vesicular
glutamate transporter (VGLUT1), a transmembrane protein localized at the glutamatergic
presynaptic terminals [12]. Through β-tubulin III labeling, we identified neuronal bodies
and dendrites and quantified VGLUT1-positive puncta, detecting a significant (p < 0.033)
increase in their density in rGO1000-treated samples (3.7 × 10−3 ± 0.2 × 10−3 a.u. for
control and 5.5 × 10−3 ± 0.5 × 10−3 a.u. for rGO1000 treated cultures, Figure 4H,I).
These results, together with the electrophysiological data, suggested that chronic
treatment with rGO1000 could induce a modification of network activity in rat-dissociated
neuronal cultures, that likely relies on a specific interference of the nanomaterial on synap-
tic communication.
4. Discussion
Zebrafish have been previously used to study the impact of GRMs [38–44] and were
exploited here to report that the degree of GO thermal reduction, which decreases the O/C
ratio in the nanomaterials, induces diverse GRMs effects on the sensory-motor nervous
system of vertebrates.
By using a high-throughput approach for the screening of locomotor behavior in
larvae exposed to GO, rGO650 and rGO1000, we observed that GO exhibited the strongest
impact, reducing the swimming performance at 2, 4 and 6 h of incubation and destroying
the pattern of navigation strategy. This last effect was specific for GO, as larvae treated with
rGO materials did not modify turn-angle behavior. In addition, the reduced nanomaterials
induced an improvement of the swimming performance detected starting from 4 h for
rGO1000 and 24 h for rGO650.
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The analysis of zebrafish anatomy together with that of the nervous system morpho-
logical aspects did not reveal macroscopic alterations, suggesting that the GRMs modified
locomotor behavior did not rely on an altered structure of the larvae, but more likely on
functional changes of the sensory-motor system. The incubation time adopted (up to 24 h)
could have prevented the development of anatomic alterations, previously described upon
longer incubation with GO [39]. Here we opted for relatively brief ranges of exposure
but at a high concentration, matching those typically used for nanotoxicology studies in
zebrafish [45,46], as our preliminary analysis of GRMs dispersion in solution revealed
that the large majority of the materials settled down within few hours, impairing any
precise control or prediction of the nanomaterial concentrations during longer treatments
(Supplementary Figure S3).
GO and rGO differ not only for the opposite impact on locomotor performance (see
below) but also in terms of onset and duration of these effects; ultimately the influence
of rGO materials in swimming behavior is slower but persistent. A number of factors
might be responsible for such different pharmacokinetics. First, GO materials can undergo
biodegradation in in vivo young zebrafish [47] and this would explain the recovery of
function in larvae treated with GO after 24 h. Second, rGO materials may be oxidized
via cellular reactive oxygen species in forms presenting an enhanced number of oxygen-
containing functional groups on the rGO surface [15]. Thus, once internalized in zebrafish,
the nanomaterials could undergo different enzymatic processes of degradation and/or
transformation, and the resulting products might further influence the nervous system.
Third, the modification of the GO surface chemistry through thermal reduction affects
other properties of the materials, such as the surface charge, the wettability, the electrical
conductivity and the dispersibility [14,24]. As shown by our experiments (Supplementary
Figures S3 and S5), the initial transmission varied significantly depending on the nature
of the nanomaterial (Supplementary Figures S3 and S4), although the concentration was
identical. This is related to the different optical properties (GO is dark brown, while the
reduction leads to a darkening of the sample) but also to the initial dispersion state, which
was certainly much better for hydrophilic GO compared to the much more hydrophobic
rGO samples. The presence of salts in the water is also known to modify the stability of the
nanomaterials in water. This is probably what explains, in the case of GO, the increase in
sedimentation speed after 18 h (Supplementary Figure S5), while this was not observed in
the case of the rGO samples. Experimental data suggest that during the first 18 h at least,
the exposure was very similar whatever the nature of the sample, even if the sedimentation
speed was a little faster for rGO1000 compared to rGO650, as expected due to the different
O/C ratio.
GO and rGO1000 induced opposite outcomes on zebrafish locomotor performance.
GO has been reported to exert their action specifically targeting neuronal synapses by
reducing the release of presynaptic vesicles [12,13], an effect in accordance with the transient
inhibition in locomotion reported here. Indeed, GO inhibition of swimming behavior
detected in the current study is in line with a previous study which reported that when
GO materials (even if with different physical and chemical properties with respect to those
used in this work) were injected in the zebrafish spinal cord, they inhibited locomotor
activity due to GO direct interference with the release of neurotransmitter, resulting in a
reduction of the synaptic activity in the spinal network [13].
On the contrary, little is known about rGO1000 ability to increase network excitability.
Although here we did not directly monitor zebrafish spinal synapses; we observed that
rGO1000, when chronically incubated with dissociated rat neuronal cultures, were respon-
sible for an enhancement in both the frequency and amplitude of sPSCs, together with
an increment in the number of glutamate containing synaptic vesicles in the presynaptic
terminals of neurons.
Considered our electrophysiological results and some studies reporting that GRMs
administered in the water of developing zebrafish can accumulate in the brain [40,48], it is
reasonable to think that the modification of locomotor activity observed in zebrafish treated
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with rGO materials could arise from the interference of these materials with the spinal
neuronal network. Since we treated zebrafish at a developmental stage in which larvae
do not feed autonomously [19], we can exclude that GRMs were internalized through
the digestive system. We hypothesize that GRMs may enter through the respiratory
system, and, as reported for other nanomaterials [49], hence translocate to the blood
circulation. Thanks to the ability of GRMs in crossing the blood–brain barrier [9], finally
the nanomaterials may pass from the bloodstream to the central nervous system. As an
alternative, GRMs might be internalized by the larvae through the olfactory system, already
present at this early developmental stage [50], and reach the central nervous system by
means of the nerve endings in the olfactory epithelium projecting to the brain, similarly to
what observed for other nanoparticles [51].
Although we cannot exclude a form, yet unknown, of direct synaptic interference, we
favor the hypothesis that rGO1000, presenting truly different physical properties after the
thermal reduction respect to GO, once in the biological environment, affected indirectly
certain cellular pathways that have as a downstream effect the modulation of synaptic
activity. At least 30 proteins, located in neurons and glial cells, have been reported to control
or modulate glutamatergic signaling [52]. Alternatively, the reduced biocompatibility of
rGO might have triggered a tissue inflammatory response [53] with consequent release of
cytokines, known to improve network excitability [54].
Finally, regarding the GO-dependent modification of the navigation strategy, the only
long-lasting effect of GO in our experiments, it is tentative to speculate that GO transiently
impaired synapses within the sensory-motor structures important for phototaxis during
a time window that is critical for the correct development of this behavior [55,56], thus
resulting in an unreversible alteration in the network maturation and the related emerging
behavior. Understanding whether this holds true will require exquisite neurophysiological
investigation in the future.
5. Conclusions
GRMs are a family of materials characterized by a variety of nanoparticles with
different sizes and chemical compositions. Such heterogeneity makes it difficult to dissect
how a specific physical and/or chemical GRMs feature is relevant in dictating their impact
on the nervous system. In this work, by using larval zebrafish in a high-throughput
screening system for the analysis of locomotor behavior, we reported that GO materials
with different degrees of thermal reduction affect the sensory-motor nervous system
with opposite effects and timing, with GO impairing swimming performance with short
latency while reduced materials enhancing it in the long-term period. Electrophysiological
evidence obtained in rat neuronal cultures suggests that such effects might depend on
the interference of nanomaterials with synaptic communication. We concluded that the
manipulation of a single GRMs chemical property, as the degree of GO reduction, is enough
to induce differential effects of nanomaterials on nervous system function.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/nano11092161/s1, Figure S1. Characterization of GO and rGO materials; Figure S2. GO
and rGO induces modifications in swimming speed; Figure S3. Turbiscan analysis: transmission
vs. time (24 h-monitoring) for GO, rGO650 and rGO1000 (raw transmission data); Figure S4. Tur-
biscan analysis: mean transmission value vs. time (24 h-monitoring) for GO, rGO650 and rGO1000;
Figure S5. Turbiscan analysis: variation of the mean transmission (24 h-monitoring) for GO, rGO650
and rGO1000.
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